“Labplus – innovative technology for medical diagnostics” is implemented under Sub-measure 1.1.1 Industrial research and development work implemented by enterprises of the Smart Growth Operational Programme 2014-2020. The main goal of the project is to develop a worldwide unique medical diagnostic technology that enables proposing a set of tests without the participation of a doctor and remotely suggesting the causes of pathology.

"Labplus Healthcare" co-financed by the European Union under the Smart Growth Operational Program 2014-2020, Measure 1.3: R&D activity financed with capital funds participation, Sub-measure 1.3.1: Support for R&D projects at the ‘pre-seed’ stage by proof of concept funds – BRIdge Alfa. The goal is to develop and implement a technological solution for medical platforms and medical portals that will enable automatic forecasting based on the results of laboratory tests and personalized medical interview.

Video material realised with EU subsidies as part of the project implementation: "Labplus - a globally innovative medical diagnostics technology".